Retraction Note: Cancer Cell International (2020) 20:592
10.1186/s12935-020-01693-y.
The Editor in Chief has retracted this article. Following publication concerns were raised regarding a number of figures, including but not limited to:
The TMZ 0hr panel in Fig. 2a appears similar to the FDPs 0h panel in Fig. 3 in [1] and the BRD4-KO#1 0h panel in Fig. 2C in [2].
The Vector and CtBP1 bands in Fig. 3B appear similar to U251 Vector and b-catenin bands in Fig. 6G in [3] and p62 and b-actin blots in Fig. 3B in [4].
The p-62 u87/TMZ-R in Fig. 3E appears similar to the Mcl-1 CHX blot in Fig. 4C in [5] and the p-PI3K GIST430 in [2].
The Editor-in-Chief therefore no longer has confidence in the results and conclusions of this article. The authors did not state explicitly whether they agree to this retraction.
Footnotes
The online version of the original article can be found at 10.1186/s12935-020-01693-y.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Huiling Qu, Xiaofu Song and Zhuyin Song contributed equally to this work.
References
- 1.Chen Z, Chen G, Zhao H. FDPS promotes glioma growth and macrophage recruitment by regulating CCL20 via Wnt/β-catenin signalling pathway. J Cell Mol Med. 2020;24(16):9055–66. doi: 10.1111/jcmm.15542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Mu J, Sun P, Ma Z, Sun P. Bromodomain and extraterminal domain inhibitor enhances the antitumor effect of imatinib in gastrointestinal stromal tumours. J Cell Mol Med. 2020;24(4):2519–30. doi: 10.1111/jcmm.14945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Tian T, Guo T, Zhen W, Zou J, Li F. BET degrader inhibits tumor progression and stem-like cell growth via Wnt/β-catenin signaling repression in glioma cells. Cell Death Dis. 2020;11(10):1–13. doi: 10.1038/s41419-020-03117-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Wang Z, Zhao Y, Xu H, Liang F, Zou Q, Wang C, Lin F. CtBP1 promotes tumour-associated macrophage infiltration and progression in non–small‐cell lung cancer. J Cell Mol Med. 2020;24(19):11445–56. doi: 10.1111/jcmm.15751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lin L, Ding D, Xiao X, Li B, Cao P, Li S. (2020). Trametinib potentiates TRAIL-induced apoptosis via FBW7‐dependent Mcl‐1 degradation in colorectal cancer cells. Journal of Cellular and Molecular Medicine, 24(12), 6822–6832. 10.1111/jcmm.15336 [DOI] [PMC free article] [PubMed]